Preclinical Services | Drug Safety & Efficacy Studies | Charles River

preclinical services 

Charles River has the proven experience, range of services and expertise to help you successfully initiate and complete critical phases of preclinical drug development by designing, performing and documenting safety tests that meet the appropriate regulatory requirements before and after clinical trials begin. Our scientific and regulatory staff are committed to providing exactly what you need with flexible solutions, accelerated timelines and customized approaches. For your IND-enabling program proposal, click here.

Charles River’s preclinical newsletter, the Researcher, contains detailed information designed to support your research. These publications are now available online through our information portal, The Source.

To register for The Source, please click here.
Already registered?  Please click here to login.



Discover the full range of Charles River Products and Services
The Source

For more information, contact us at:

1.877.CRIVER.1 (1.877.274.8371)
askcharlesriver@crl.com

view all

News & Events

view all
May 14 - New Models for Evaluating COPD or ...
May 11 - Expert Safety Testing to Accelerat...
Jun 17-Jun 20 -  Noordwijk aan Zee, the Netherlands - 19th MDO Meeting / 12th European ...
Jun 02-Jun 05 - Vancouver, British Columbia - CALAS
Jun 05-Jun 05 - King of Prussia, Pennsylvania - Assessment of Immunomodulation for Biol...
Jun 05-Jun 08 - Saint Germain sur l’Arbresle, France - Charles River LAL Seminar Series
view all
Scientist I Wilmington, MA
Manager International Tax Wilmington, MA

Charles River Laboratories, Inc.